INS and type 1 diabetes mellitus: Type 1 diabetes, is a chronic lifelong auto-immune condition characterised by the bodily destruction of one’s pancreatic insulin producing beta cells, requiring an intense management regime of multiple daily injections (MDIs) or pump therapy to provide artificial insulin (Maahs et al., 2010).